NetworkNewsBreaks – CytoDyn Inc. (CYDY) Interim CMO to Present at 11th Annual Conference on Stem Cell and Regenerative Medicine

CytoDyn Inc. (OTCQB: CYDY), a biotechnology company developing innovative treatments for multiple therapeutic indications, this morning announced that Richard G. Pestell, M.D., Ph.D., president of the Pennsylvania Cancer and Regenerative Medicine Research Center, distinguished professor at the Baruch S. Blumberg Institute and interim chief medical officer of CytoDyn, will deliver the keynote plenary speech at the 11th Annual Conference on Stem Cell and Regenerative Medicine in Helsinki, Finland. Pestell’s presentation, titled ‘Cancer stem cells, genetic drivers and therapeutic targeting via CCR5’, is scheduled to take place on Monday, October 15, from 10-11 am EEST. Pestell will present recent scientific evidence demonstrating the effectiveness of PRO 140 (leronlimab), which is shown to bind to CCR5 in human breast cancer, block CCR5 signaling induced by cytokines and block human breast cancer cell invasion.

To view the full press release, visit http://nnw.fm/SgzM0

About CytoDyn

CytoDyn is a biotechnology company developing innovative treatments for multiple therapeutic indications based on PRO 140 (leronlimab), a novel humanized monoclonal antibody targeting the CCR5 receptor. CCR5 plays a key role in the ability of HIV to enter and infect healthy T-cells.  The CCR5 receptor is also implicated in tumor metastasis and in immune-mediated illnesses such as graft-vs-host disease (GvHD) and NASH. CytoDyn has successfully completed a Phase 3 pivotal trial with PRO 140 in combination with standard anti-retroviral therapies in HIV-infected treatment-experienced patients. The Company plans to seek FDA approval for PRO 140 in combination therapy and plans to complete the filing of a Biological License Application (BLA) in the first quarter of 2019 for that indication. CytoDyn is also conducting a Phase 3 investigative trial with PRO 140 as a once-weekly monotherapy for HIV-infected patients, and plans to initiate a registration-directed study of PRO 140 monotherapy indication, which if successful, could support a label extension. Clinical results to date from multiple trials have shown that PRO 140 can significantly reduce viral burden in people infected with HIV with no reported drug-related serious adverse events (SAEs). Moreover, results from a Phase 2b clinical trial demonstrated that PRO 140 monotherapy can prevent viral escape in HIV-infected patients, with some patients on PRO 140 monotherapy remaining virally suppressed for more than four years. CytoDyn is also conducting a Phase 2 trial to evaluate PRO 140 for the prevention of GvHD and expects to initiate clinical trials with PRO 140 in metastatic triple-negative breast cancer in 2018. For more information, visit the company’s website at www.CytoDyn.com

More from NetworkNewsBreaks

NetworkNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Investee Adds Taxation Reporting Technology to its Proprietary Compliance Platform NetworkNewsBreaks – First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) Announces Results of Independent Studies Supporting Restart of Canadian Refinery NetworkNewsBreaks – The Flowr Corporation (TSX.V: FLWR) Ships Initial Purchase Order from the NSLC

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire has received compensation from CytoDyn Inc. for providing certain investor relations, marketing and social media services, including the preparation of this report, and expects to receive additional compensation for such services in the future. This compensation includes a monthly program fee.

Latest News

China suspends tariff hikes on US cars, auto parts

Dec 15, 2018

BEIJING — China announced a 90-day suspension on Friday of tariff hikes on U.S. cars, trucks and auto parts following its cease-fire in a trade battle with Washington that threatens global economic growth. The suspension is China's first step in response to President Donald Trump's Dec. 1 agreement to suspend U.S. tariff hikes for a similar 90-day period while the two sides negotiate over American complaints about Beijing's technology policy and trade surplus. China has indicated it plans to move ahead with the talks despite strains over the arrest of a Chinese technology executive in Canada to face possible U.S....

The Latest: China confirms holding 2 Canadians

Dec 15, 2018

BEIJING — The Latest on the detentions in China of two Canadian men (all times local): 3:55 p.m. China has confirmed it has detained two Canadian men, saying they were being detained on suspicion of "endangering national security." Foreign Ministry spokesman Lu Kang said Thursday that entrepreneur Michael Spavor and former Canadian diplomat Michael Kovrig were taken into custody on Monday. Lu says Canada has been informed of the detentions, but declined to say whether the men have been provided with lawyers. He says they are being handled separately. The two cases ratchet up pressure on Canada, which is holding...

Detention of Canadians raises stakes in China-US-Canada row

Dec 15, 2018

BEIJING — China confirmed Thursday that it has detained two Canadian men, raising the stakes in a three-way dispute over a Chinese technology executive facing possible extradition from Canada to the United States. Entrepreneur Michael Spavor and former diplomat Michael Kovrig were taken into custody Monday on suspicion of "engaging in activities that endanger the national security" of China, said foreign ministry spokesman Lu Kang. Lu said Canada was informed but declined to say whether the men have been provided with lawyers. He said the cases are being handled separately by local bureaus of the national intelligence agency in Beijing,...

Analysis: China plays hardball with ex-diplomat's seizure

Dec 15, 2018

BEIJING — China is playing hardball with the detention of a former Canadian diplomat days after Canada arrested a leading Chinese executive. In many ways it looks like a classic Chinese response to perceived slights: Deny any wrongdoing, seize the moral high ground and exert maximum pressure to extract concessions. But Beijing's detention of Michael Kovrig also reflects an increasingly bold approach to international disputes under President Xi Jinping, who has overseen a vast expansion of China's diplomatic, military and economic power. China has often retaliated against foreign governments and corporations in diplomatic disputes, but rarely by holding a foreign...

China and US discuss plans for trade talks

Dec 15, 2018

BEIJING — China's economy czar and U.S. trade envoys discussed plans for talks on a tariff battle, the government said Tuesday, indicating that negotiations are going ahead despite tension over the arrest of a Chinese tech executive. Vice Premier Liu He talked by phone with Treasury Secretary Steven Mnuchin and U.S. Trade Representative Robert Lighthizer about "the promotion of the next economic and trade consultations," said a two-sentence Commerce Ministry statement. It gave no other details. Lighthizer's office confirmed the phone call with Liu but provided no additional information. The announcement indicated that talks are on track despite China's weekend...

Sign up now!